| Dells Nursing And Rehab Center Inc | |
| 1400 Thresher Dr, Dell Rapids, South Dakota 57022 | |
| (605) 428-5478 | |
| Name | Dells Nursing And Rehab Center Inc |
|---|---|
| Location | 1400 Thresher Dr, Dell Rapids, South Dakota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 50 |
| Occupancy Rate | 82.2% |
| Medicare ID (CCN) | 435129 |
| Legal Business Name | Dells Nursing & Rehab Center |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1063781763 |
| Organization Name | DELLS NURSING & REHAB CENTER |
| Address | 1400 Thresher Dr, Dell Rapids, SD 57022 |
| Phone Number | 605-428-5478 |
News Archive
Research reported in The Lancet this week details the second case of variant Creutzfeldt-Jakob disease (vCJD) infection that was probably caused by blood transfusion. The rogue prion responsible for vCJD was identified at postmortem five years after an elderly person received a blood transfusion from a donor who later developed vCJD.
A psychologist, Elaine Brohan, from the University of Surrey in Guildford, England, has found that family doctors are having to redefine their traditional "father figure" role because patients increasingly turn to the internet for medical advice, and GP's are often being confronted by patients armed with website print-outs.
WellPoint, the parent company of Anthem Blue Cross, has canceled an investor meeting "so that executives can prepare for a congressional hearing on the company's large rate hikes in California," the Los Angeles Times reports. "A subcommittee of the House Committee on Energy and Commerce has called WellPoint Inc. Chief Executive Angela F. Braly to testify Feb. 24 about planned premium increases of as much as 39% for many of Anthem's 800,000 individual policyholders in California."
Eurand has announced that Eurand Pharmaceuticals Ltd. initiated the rolling submission of its new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for Zentase for the treatment of Exocrine Pancreatic Insufficiency (EPI). Zentase (formerly EUR-1008), the company's lead product candidate, has been granted fast-track designation by the FDA.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Research reported in The Lancet this week details the second case of variant Creutzfeldt-Jakob disease (vCJD) infection that was probably caused by blood transfusion. The rogue prion responsible for vCJD was identified at postmortem five years after an elderly person received a blood transfusion from a donor who later developed vCJD.
A psychologist, Elaine Brohan, from the University of Surrey in Guildford, England, has found that family doctors are having to redefine their traditional "father figure" role because patients increasingly turn to the internet for medical advice, and GP's are often being confronted by patients armed with website print-outs.
WellPoint, the parent company of Anthem Blue Cross, has canceled an investor meeting "so that executives can prepare for a congressional hearing on the company's large rate hikes in California," the Los Angeles Times reports. "A subcommittee of the House Committee on Energy and Commerce has called WellPoint Inc. Chief Executive Angela F. Braly to testify Feb. 24 about planned premium increases of as much as 39% for many of Anthem's 800,000 individual policyholders in California."
Eurand has announced that Eurand Pharmaceuticals Ltd. initiated the rolling submission of its new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for Zentase for the treatment of Exocrine Pancreatic Insufficiency (EPI). Zentase (formerly EUR-1008), the company's lead product candidate, has been granted fast-track designation by the FDA.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.08 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.17 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 37.68 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.62 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.8 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.85 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.59 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.3 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 70.42 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.89 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.05 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.11 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 78.9 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 83.33 | 82.93 |
News Archive
Research reported in The Lancet this week details the second case of variant Creutzfeldt-Jakob disease (vCJD) infection that was probably caused by blood transfusion. The rogue prion responsible for vCJD was identified at postmortem five years after an elderly person received a blood transfusion from a donor who later developed vCJD.
A psychologist, Elaine Brohan, from the University of Surrey in Guildford, England, has found that family doctors are having to redefine their traditional "father figure" role because patients increasingly turn to the internet for medical advice, and GP's are often being confronted by patients armed with website print-outs.
WellPoint, the parent company of Anthem Blue Cross, has canceled an investor meeting "so that executives can prepare for a congressional hearing on the company's large rate hikes in California," the Los Angeles Times reports. "A subcommittee of the House Committee on Energy and Commerce has called WellPoint Inc. Chief Executive Angela F. Braly to testify Feb. 24 about planned premium increases of as much as 39% for many of Anthem's 800,000 individual policyholders in California."
Eurand has announced that Eurand Pharmaceuticals Ltd. initiated the rolling submission of its new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for Zentase for the treatment of Exocrine Pancreatic Insufficiency (EPI). Zentase (formerly EUR-1008), the company's lead product candidate, has been granted fast-track designation by the FDA.
› Verified 8 days ago
Dells Nursing And Rehab Center Inc Location: 1400 Thresher Dr, Dell Rapids, South Dakota 57022 Phone: (605) 428-5478 |